We're currently experiencing extremely high call volumes. We're very sorry for any inconvenience this might cause. If you need help with your account, please visit our Help Centre, or email us and we’ll get back to you as soon as we can. For more information and tips on managing your account online please visit www.hl.co.uk/coronavirus

We’re experiencing high call volumes, please check FAQs before calling.

Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account

US Stem Cell Inc (USRM) Ord USD0.001

Sell:$0.0082 Buy:$0.0082 Change: No change
Market closed |  Prices as at close on 8 April 2020 | Switch to live prices |
Sell:$0.0082
Buy:$0.0082
Change: No change
Deal now Deal for just £11.95 per trade in a Fund and Share Account
Market closed |  Prices as at close on 8 April 2020 | Switch to live prices |
Sell:$0.0082
Buy:$0.0082
Change: No change
Market closed |  Prices as at close on 8 April 2020 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

U.S. Stem Cell, Inc., formerly Bioheart, Inc., is a biotechnology company. The Company is focused on the discovery, development and, subject to regulatory approval, commercialization of autologous cell therapies for the treatment of chronic and acute heart damage. Its MyoCell is a clinical therapy designed to populate regions of scar tissue within a patient's heart with autologous muscle cells, or cells from a patient's body, for the purpose of improving cardiac function in chronic heart failure patients. Its AdipoCell is a cell therapy with multiple possible treatment applications using autologous adipose cells. Its business includes the development of cell therapy products, as well as physician and patient-based regenerative medicine/cell therapy training services, and the sale of cell collection and treatment kits for humans and animals, and the operation of a cell therapy clinic. It operates through divisions, including US Stem Cell Training, Vetbiologics and US Stem Cell Clinic.

Contact details

Address:
1560 Sawgrass Corporate Pkwy Fl 4
SUNRISE
33323-2855
United States
Telephone:
+1 (954) 8351500
Website:
us-stemcell.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
USRM
ISIN:
US90350U1007
Market cap:
$3.34 million
Shares in issue:
407.11 million
Sector:
Biotechnology
Exchange:
OTC Bulletin Board
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • William Murphy
    Chairman of the Board
  • Mike Tomas
    President, Chief Executive Officer, Chief Financial Officer, Director

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.